Catalyst Wire Dossier Catalyst Wire Dossier

Icaritin Soft Capsules

icaritin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Icaritin Soft Capsules, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence [Phase 2]

See pricing